dabigatran has been researched along with Pancreatic Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chabot, JA; Dwyer, FA; Jackson, TL; Kluger, MD; Morgan, JA; Rashid, MF; Schrope, BA | 1 |
1 other study(ies) available for dabigatran and Pancreatic Neoplasms
Article | Year |
---|---|
Dabigatran (Pradaxa) Is Safe for Extended Venous Thromboembolism Prophylaxis After Surgery for Pancreatic Cancer.
Topics: Administration, Oral; Aged; Antithrombins; Dabigatran; Female; Humans; Male; Pancreatectomy; Pancreatic Neoplasms; Postoperative Complications; Treatment Outcome; Venous Thromboembolism | 2019 |